Advertisement

Bharat Biotech commences exports COVID-19 vaccine Covaxin; more countries to avail India-made jabs from Dec

03:02 PM Nov 29, 2021 | PTI

New Delhi: Vaccine maker Bharat Biotech on Monday said it has commenced exports of COVID-19 vaccine Covaxin, and long-pending export orders have been executed during November.

"Long pending export orders have been executed during November, to be further expanded during the following months. With the number of countries that have granted emergency use approvals for Covaxin increasing, exports to additional countries will also commence from December," Bharat Biotech said in a tweet.

Advertisement
Advertisement

The company, however, did not provide details about the countries to which exports have commenced or about the additional countries to which the exports will start from December.

Advertisement

"Bharat Biotech thanks the Government of India for approving exports. Covaxin will now become an integral part of the global fight against this pandemic," the tweet said.

Earlier last week, vaccine major Serum Institute of India had said that it has resumed exports of its vaccine Covishield to the international vaccine sharing programme COVAX.

(To view our epaper please Read Now. For all the latest News, Mumbai, Entertainment, Cricket, Business and Featured News updates, visit Free Press Journal. Also, follow us on Twitter and Instagram and do like our Facebook page for continuous updates on the go)

Advertisement